What is the role of hyperbaric oxygen therapy in the treatment of thromboangiitis obliterans (TAO) (Buerger disease)?

Updated: Jul 27, 2020
  • Author: Naiem Nassiri, MD; Chief Editor: Vincent Lopez Rowe, MD  more...
  • Print

Hyperbaric oxygen therapy is now an accepted adjunctive measure that has been shown to provide significant clinical improvement in patients with diabetic wounds, refractory osteomyelitis, acute limb ischemia, or necrotizing soft-tissue infection. Its use in treating TOA patients without revascularization options remains experimental; the available data are extremely limited. [20] Hyperbaric oxygen therapy does, however, provide a promising alternative treatment option that is worth investigating on larger scales.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!